English
Arabic
Chinese (Simplified)
Dutch
Esperanto
French
German
Greek
Italian
Japanese
Korean
Portuguese
Russian
Spanish
UrduRutgers team that created the new COVID vaccine aims to partner with a pharmaceutical company to launch human trials.
Tag: Vaccine
Method for improving seasonal flu vaccines also aids pandemic prediction
The seasonal flu vaccine is less effective in some years than others. New St. Jude research showed one reason behind this lack of efficacy is the inclusion of flu strains with an unstable viral protein.
New research reveals possible COVID vaccine blood clot connection
A new Australian study led by SAHMRI and Flinders University has uncovered fundamental differences in how the AstraZeneca and Pfizer COVID-19 vaccines impact the immune system.
Main Line Health researcher releases world’s first complete resource on molecular structure of virus that causes COVID-19
A biomedical researcher at the Lankenau Institute for Medical Research, part of Main Line Health, has created a groundbreaking resource for scientists seeking to develop new and better vaccines in the fight against COVID-19.
Cleveland Clinic Announces Next Step in Preventive Breast Cancer Vaccine Study
Cleveland Clinic researchers have launched the next step in their novel study of a vaccine aimed at preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
National Primate Research Center of Thailand Chulalongkorn University Symposium 2023
As its 11th-anniversary approaches, the National Primate Research Center of Thailand Chulalongkorn University (NPRCT-CU) and the Primates Enterprise Co., Ltd. are pleased to announce two events in February 2023:
Improving Adult Immunization Rates the Focus of Partnership Between ATS and Three Health Systems Across the U.S.
NEW YORK, NY – Jan. 17, 2023 – The American Thoracic Society is starting the new year poised to improve vaccination rates with three health system partners: University of Arizona/ Banner Health; West Virginia University Hospitals, Inc.; and San Francisco Health Network/ University of California.
A Three-Dose Malaria Vaccine Shows Safety, Efficacy in West African Adults
A three-dose regimen of a whole-parasite vaccine against malaria – called Plasmodium falciparum sporozoite (PfSPZ) vaccine – demonstrated safety and efficacy when tested in adults living in Burkina Faso, West Africa, which has endemic malaria.
What You Should Know About Mpox
Find out what special pathogens expert Erika Cheung, MSN, RN, CPN, has to say about the disease, which the WHO has declared a public health emergency of international concern. Since May 18, 2022, cases of mpox have been spreading in the United States, including California. On July 23, 2022, the World Health Organization (WHO) declared the current outbreak a public health emergency of international concern.
Texas Biomed at forefront of Sudan ebolavirus biomedical R&D
A Sudan ebolavirus vaccine and antibody therapeutic tested at Texas Biomedical Research Institute have been sent to Uganda as part of efforts to control the outbreak there.
Flu shots are recommended for those 65 and older as cases rise
With flu cases on the rise, geriatric specialists at UT Southwestern Medical Center say vaccinations are particularly important this year for people 65 and older who are more at risk from complications than other age groups.
Clover’s vaccine candidate reduced household transmission of SARS-CoV-2 in study
The study, a collaboration between Clover and the International Vaccine Institute, showed that a household contact was 84% less likely to get a SARS-CoV-2 infection when the infected household member had received SCB-2019 (CpG 1018/Alum) compared to placebo
Rutgers Infectious Disease Expert Can Discuss Staying Healthy at Holiday Gatherings
Diana Finkel, an assistant professor of medicine and director of the Infectious Disease Fellowship Program at Rutgers New Jersey Medical School, is available for interviews on how people can minimize their chances of getting sick at holiday gatherings (without eating…
Rutgers Medical Toxicologist and Addiction Expert Available to Discuss Fentanyl Vaccine’s Impacts
Lewis Nelson, a medical toxicologist and chair of the Department of Emergency Medicine at Rutgers New Jersey Medical School, is available to discuss the possible benefits and many uncertainties of the experimental fentanyl vaccine. “Vaccines against other noninfectious agents, such…
Study Differentiating Function of Two Immune Cells Could Improve Vaccine Design
Rutgers researchers find that one type of tissue-resident memory cell fights reinfection better than another.
Houston Methodist seeing December flu season peak numbers now
Texas already has a moderately high rate of flu cases in September. This doesn’t look good for flu season, which was uncharacteristically low last year because of masks and people isolating. Houston Methodist experts are encouraging the community to get the flu shot early. Experts say cases aren’t usually seen this high until December, which is when the season usually peaks.
Vaccinating women infected with COVID during pregnancy prior to delivery provides antibodies to newborns
FINDINGS Women with COVID in pregnancy who are subsequently vaccinated after recovery, but prior to delivery, are more likely to pass antibodies on to the child than similarly infected but unvaccinated mothers are. Researchers who studied a mix of vaccinated and unvaccinated mothers found that 78% of their infants tested at birth had antibodies.
Researchers from NAU, Washington tackling an elusive Valley Fever vaccine
Researchers from Northern Arizona University and the University of Washington School of Medicine in collaboration with the Washington National Primate Research Center received a five-year, $7.5 million grant from the National Institutes of Health to fund a groundbreaking project that they hope will result in a safe and effective vaccine for Valley Fever.
The longer the bootcamp, the better the antibodies
LJI research shows that a “slow delivery, escalating dose” vaccination strategy can prompt B cells to spend months mutating and evolving their pathogen-fighting antibodies.
Current vaccine approach not enough to eradicate measles
Current vaccination strategies are unlikely to eliminate measles, according to a new study led by faculty at the University of Georgia. The paper, which published today in The Lancet Global Health, explores the feasibility of eliminating measles and rubella using predominant vaccination strategies in 93 countries with the highest disease burden.
UCLA leads CDC-funded study on effectiveness of vaccines, boosters in ‘next phase’ of COVID
The David Geffen School of Medicine at UCLA has been awarded a $13.6 million grant from the Centers for Disease Control and Prevention to continue to study the effectiveness of COVID-19 vaccines and the long-term impact of infection among U.S. health care workers. The new yearlong grant project follows the 2020–21 Preventing Emerging Infections Through Vaccine Effectiveness Testing study, or PREVENT I, which was among the first to demonstrate the real-world benefit of mRNA vaccines in preventing symptomatic infection following their authorization by the Food and Drug Administration.
Researchers discover potential treatment for Chagas disease
Researchers from the University of Georgia have discovered a potential treatment for Chagas disease, marking the first medication with promise to successfully and safely target the parasitic infection in more than 50 years. Human clinical trials of the drug, an antiparasitic compound known as AN15368, will hopefully begin in the next few years.
Enhancing the effect of protein-based COVID-19 vaccines
Adding an ingredient called an adjuvant can help vaccines elicit a more robust immune response. In a study in ACS Infectious Diseases, researchers report a substance that boosted the immune response to an experimental COVID-19 shot in mice by 25 times, compared to injection with the vaccine alone.
Preparing for Class: Johns Hopkins Children’s Center Experts Available for Interviews Related to Going Back to School
As we approach the time of year when students switch from vacation mode to school mode, Johns Hopkins Children’s Center experts are available for interviews on a variety of back-to-school-related topics to share advice for a smooth start to the new school year.
Why has Polio returned to the U.S.? Author of “Constructing the Outbreak: Epidemics in Media and Collective Memory” Katherine Foss explains.
“For too long, we’ve falsely assumed that polio has been eradicated in the U.S.,” says Katherine Foss, a professor and associate director of the School of Journalism & Strategic Media at Middle Tennessee State University. However, no cases doesn’t mean the virus has been eradicated, especially with polio still existing in the world.
Changes to GCSE science syllabus could help improve vaccine uptake new study concludes
Researchers are calling for urgent changes to the GCSE science curriculum to help equip learners with sufficient scientific literacy to be able to identify reliable sources and inform their future vaccination decision-making process.
CDI Laboratory Identifies Critical Regulators Controlling T-Cell Homeostasis Which Could Improve Cancer Therapies, Vaccines of the Future
The laboratory of Hai-Hui “Howard” Xue at the CDI published the findings of the complex and cascading molecular interactions modulating T-cell immunology in the August issue of the journal Nature Immunology.
Newly Discovered “Danger Signal” May Spur Vaccine Development and Allergy Treatment
A team of Rutgers researchers and others inject parasitic worms into mice to study how injured cells trigger an immune response.
In brief: COVID-19 vaccine does not negatively affect placental health
Vaccination against COVID-19 had no impact on the health of placentas in pregnant women, according to new research by pathologists at Weill Cornell Medicine and NewYork-Presbyterian.
Pfizer-BioNTech and AstraZeneca vaccines offer high protection against severe COVID-19, 6 months after second doses, finds study of over 7 million adults
Protection against severe COVID-19 by two doses of Pfizer-BioNTech and AstraZeneca COVID-19 vaccines remained high up to six months after second doses, finds new research which analysed NHS health record data on over seven million adults. Reassuringly, the University of Bristol-led study published in The BMJ today [July 20], found protection in older adults aged over 65 years, and in clinically vulnerable adults.
Adults with blood cancers respond to booster, not initial dose of COVID-19 vaccine
Most patients in the study mounted immune responses after a booster dose, and no patient with antibody responses died from COVID-19.
Study explores unusual interaction between viruses, live vaccines
A study of a herpes virus that infects chickens offers new insights into potentially problematic interactions between vaccines made from live viruses and the viruses they are meant to thwart.
Age may rival politics in COVID-19 vaccine debate
New research from the University of Georgia suggests age and risk perception may have as much of an effect on COVID-19 vaccine acceptance as party affiliation.
South Asian Communities in GTA disproportionately hit by COVID-19
A COVID CommUNITY – South Asian study, published in the Canadian Medical Association Journal (CMAJ) Open has found that South Asian communities living in the Greater Toronto Area (GTA) suffered disproportionately from COVID-19 in the first year of the pandemic.
COVID-19 vaccine protects people of all body weights from hospitalization and death, study of 9 million adults in England suggests
COVID-19 vaccines greatly reduced the number of cases of severe COVID-19 disease for everyone regardless of their body size, according to a new study published in The Lancet Diabetes & Endocrinology. Vaccine effectiveness was similar for those with a higher BMI and of a healthy weight, but slightly lower in the underweight group, who were also the least likely to have been vaccinated.
New universal flu vaccine offers broad protection against influenza A virus infections, researchers find
A new universal flu vaccine constructed with key parts of the influenza virus offers broad cross protection against different strains and subtypes of influenza A viruses in young and aged populations, according to a new study by researchers in the Institute for Biomedical Sciences at Georgia State University.
Interrupting the Treatment of Vulnerable People on Immune-Suppressing Medicines, Doubles Their Antibody Response to COVID-19 Booster Vaccination
A major clinical trial, led by experts at the University of Nottingham working in partnership with several Universities and NHS hospitals, has found that by interrupting the treatment of vulnerable people on long-term immune supressing medicines for two weeks after a COVID-19 booster vaccination, their antibody response to the jab is doubled.
Immune Molecules From a Llama Could Provide Protection Against a Vast Array of SARS-like Viruses Including COVID-19, Researchers Say
Mount Sinai-led researchers have shown that tiny, robust immune particles derived from the blood of a llama could provide strong protection against every COVID-19 variant, including Omicron, and 18 similar viruses.
University of Pennsylvania’s First NFT Commemorates mRNA Research
The historic scientific breakthrough at the Perelman School of Medicine at the University of Pennsylvania that helped lead the world’s fight against COVID-19 through mRNA-based vaccines is being commemorated through a non-fungible token—a digital asset to be auctioned by Christie’s—that will support ongoing research at Penn.
Loyola Medicine Pediatric Experts Available to Discuss Possible Approval of COVID-19 Vaccines for Children Under 5
MAYWOOD, IL – Panels from the Food and Drug Administration (FDA) and the Centers for Disease Control (CDC) are meeting this week to consider authorizing COVID-19 vaccines for children under the age of 5 from both Pfizer and Moderna. The…
Mount Sinai Researchers Develop a Rapid Test to Measure Immunity to COVID-19
Mount Sinai researchers have developed a rapid blood assay that measures the magnitude and duration of someone’s immunity to SARS-CoV-2, the virus that causes COVID-19. This test will allow large-scale monitoring of the population’s immunity and the effectiveness of current vaccines to help design revaccination strategies for vulnerable immunosuppressed individuals, according to a study published in Nature Biotechnology in June.
Heart Failure Patients Unvaccinated Against COVID-19 Are Three Times More Likely to Die From It Than Boosted Heart Failure Patients
EMBARGOED UNTIL JUNE 9, 2022, 10AM EST (New York, NY – June 9, 2022) – Heart failure patients who are unvaccinated against SARS-CoV-2, the virus that causes COVID-19, are three times more likely to die if infected with the virus…
Data contradict fears of COVID-19 vaccine effects on pregnancy and fertility
Study adds further evidence that vaccination is protective and safer than COVID-19 infection.
Study shines light on longevity of COVID-19 immune response
By uniting research from 8 cohorts across the U.S., a group of researchers has accelerated collection of data integral in answering questions about immune responses needed for long lasting protection from SARS-CoV-2.
Cleveland Clinic Appoints Ted Ross, Ph.D., as Global Director of Vaccine Development
Ted Ross, Ph.D., has been appointed Global Director of Vaccine Development at Cleveland Clinic.
In this newly created role, he will lead the development of novel vaccine platforms for a variety of infectious diseases, including influenza, HIV and COVID-19. A highly renowned scientist with expertise in virology, vaccines, immunology and microbiology, Dr. Ross’ research focuses on the design of new vaccines and the implementation of new vaccine trials.
True and false claims: online behaviors behind COVID-19 vaccine uptake
Vaccine uptake constitutes a key barometer as governments lead the communities out of the COVID-19 pandemic. Facts and fake news have apparently influenced vaccination willingness. But how valid is this proposition?
Flu Season Underway Amid Ongoing COVID-19 Pandemic
For the second straight year, flu season is emerging against the backdrop of the COVID-19 pandemic. While the number of flu cases was relatively low last year, experts at Johns Hopkins Medicine say that this year, it could be much higher.
New COVID vaccine design is easier to manufacture, doesn’t need cold storage
Currently available COVID vaccines require cold storage and sophisticated manufacturing capacity, which makes it difficult to produce and distribute them widely, especially in less developed countries.
In Covid-19 Vaccinated People, Those with Prior Infection Likely to Have More Antibodies
In what is believed to be one of the largest studies of its kind, Johns Hopkins Medicine researchers have shown that antibody levels against SARS-CoV-2 (the COVID-19 virus) stay more durable — that is, remain higher over an extended period of time — in people who were infected by the virus and then received protection from two doses of messenger RNA (mRNA) vaccine compared with those who only got immunized.
For people of color in L.A., misinformation, past injustices contribute to vaccine hesitancy
New UCLA research finds that misinformation and politicization, awareness of past injustices involving medical research, and fears about the inequitable distribution of vaccines all contributed to hesitancy to be vaccinated among Los Angeles’ People of Color.